Literature DB >> 17988877

Characterization of thyroid hormone receptor alpha (TRalpha)-specific analogs with varying inner- and outer-ring substituents.

Cory A Ocasio1, Thomas S Scanlan.   

Abstract

Analogs of the TRalpha-specific thyromimetic CO23 were synthesized and analyzed in vitro using competitive binding and transactivation assays. Like CO23, all analogs bind to both thyroid hormone receptor subtypes with about the same affinity; however, modification of CO23 by derivatization of the 3' position of the outer-ring or replacement of the inner-ring iodides with bromides attenuates binding. Despite lacking a preference in binding to TRalpha, all analogs display TRalpha-specificity in transactivation assays using U2OS and HeLa cells. At best, several agonists exhibit an approximately 6-12-fold preference in transactivation when tested with TRalpha in HeLa cells. One analog, CO24, showed in vivo TRalpha-specific action in a tadpole metamorphosis assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988877      PMCID: PMC2676442          DOI: 10.1016/j.bmc.2007.10.040

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Design and characterization of a thyroid hormone receptor alpha (TRalpha)-specific agonist.

Authors:  Cory A Ocasio; Thomas S Scanlan
Journal:  ACS Chem Biol       Date:  2006-10-24       Impact factor: 5.100

Review 2.  Small-molecule triggers of tadpole metamorphosis.

Authors:  Blake R Peterson
Journal:  ACS Chem Biol       Date:  2006-10-24       Impact factor: 5.100

3.  Intramolecular carbolithiation of allyl o-lithioaryl ethers: a new enantioselective synthesis of functionalized 2,3-dihydrobenzofurans.

Authors:  José Barluenga; Francisco J Fañanás; Roberto Sanz; César Marcos
Journal:  Chemistry       Date:  2005-09-05       Impact factor: 5.236

4.  Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues.

Authors:  Matthew E Hart; Katherine L Suchland; Motonori Miyakawa; James R Bunzow; David K Grandy; Thomas S Scanlan
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

5.  Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism.

Authors:  Andrew K Shiau; Danielle Barstad; James T Radek; Marvin J Meyers; Kendall W Nettles; Benita S Katzenellenbogen; John A Katzenellenbogen; David A Agard; Geoffrey L Greene
Journal:  Nat Struct Biol       Date:  2002-05

Review 6.  Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects.

Authors:  Eugene Morkin; Paul Ladenson; Steven Goldman; Cynthia Adamson
Journal:  J Mol Cell Cardiol       Date:  2004-12       Impact factor: 5.000

7.  Regulation of gene expression in cardiomyocytes by thyroid hormone and thyroid hormone analogs 3,5-diiodothyropropionic acid and CGS 23425 [N-[3,5-dimethyl-4-(4'-hydroxy-3'-isopropylphenoxy)-phenyl]-oxamic acid].

Authors:  Cynthia Adamson; Niranjan Maitra; Joseph Bahl; Kevin Greer; Scott Klewer; James Hoying; Eugene Morkin
Journal:  J Pharmacol Exp Ther       Date:  2004-05-17       Impact factor: 4.030

8.  A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor.

Authors:  G Chiellini; J W Apriletti; H A Yoshihara; J D Baxter; R C Ribeiro; T S Scanlan
Journal:  Chem Biol       Date:  1998-06

Review 9.  Selective thyromimetics: tissue-selective thyroid hormone analogs.

Authors:  T S Scanlan; H A Yoshihara; N H Nguyen; G Chiellini
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

10.  Expression of the rat alpha 1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformation change as a method for its purification to homogeneity.

Authors:  J W Apriletti; J D Baxter; K H Lau; B L West
Journal:  Protein Expr Purif       Date:  1995-06       Impact factor: 1.650

  10 in total
  4 in total

1.  Increasing Thyromimetic Potency through Halogen Substitution.

Authors:  Jordan Devereaux; Skylar J Ferrara; Tania Banerji; Andrew T Placzek; Thomas S Scanlan
Journal:  ChemMedChem       Date:  2016-10-12       Impact factor: 3.466

Review 2.  Thyroid hormone receptor α1 as a novel therapeutic target for tissue repair.

Authors:  Constantinos Pantos; Iordanis Mourouzis
Journal:  Ann Transl Med       Date:  2018-06

3.  In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.

Authors:  Carmen Grijota-Martínez; Eric Samarut; Thomas S Scanlan; Beatriz Morte; Juan Bernal
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

Review 4.  Thyroid Hormone Signalling: From the Dawn of Life to the Bedside.

Authors:  Iordanis Mourouzis; Angelo Michele Lavecchia; Christodoulos Xinaris
Journal:  J Mol Evol       Date:  2019-08-27       Impact factor: 2.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.